Home LiteratureArticle Details
PMID: 3088195 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation.

The Journal of experimental medicine ·Vol. 164 ·No. 1 ·1986-07-01 ·Pages 263-79

Murphy M, Loudon R, Kobayashi M, Trinchieri G

Abstract

We have shown that lymphocytes stimulated by PHA produce colony-forming unit of granulocyte/monocyte (CFU-GM)-stimulating and -inhibiting activities, IFN-gamma, and lymphotoxin (LT). IFN-gamma is necessary for inhibition of CFU-GM by PHA-conditioned medium (CM), as shown by experiments in which removal of IFN-gamma from PHA-CM abrogated inhibition. However, experiments in which rIFN-gamma was added to IFN-gamma-depleted PHA-CM revealed the presence, in PHA-CM, of other factors that act in synergy with IFN-gamma to inhibit CFU-GM. Fractionation of PHA-CM on a Sephadex G-100 column was used to separate IFN-gamma and LT. Colony-inhibiting activity was eluted in fractions that contained both IFN-gamma and LT activities, identifying LT as a factor present in PHA-CM that synergizes with IFN-gamma to inhibit CFU-GM. Treatment of PHA-CM with mAb against either IFN-gamma or LT completely abrogated the colony-inhibiting activity, demonstrating a requirement for both lymphokines in PHA-CM-induced inhibition of CFU-GM. Experiments using rIFN-gamma and preparations of purified LT confirmed that neither lymphokine alone, when added to bone marrow cells at the concentrations present in PHA-CM, strongly inhibited day 7 or day 14 CFU-GM, but that the two lymphokines, added together, behaved synergistically to inhibit CFU-GM by up to 70%. The inhibition observed using purified preparations of lymphokines shows that synergy between IFN-gamma and LT is sufficient to explain PHA-CM-induced inhibition of CFU-GM. Our findings suggest that activated T cells regulate hematopoiesis through the release of inhibitory as well as stimulatory factors, and that the simultaneous production of IFN-gamma and LT may represent a mechanism of suppression of hematopoiesis in the cases of bone marrow failure associated with the presence of activated T cells.

MeSH Terms
Animals Antibodies, Monoclonal/physiology Cell Line Chromatography, Gel Colony-Forming Units Assay Colony-Stimulating Factors/physiology Drug Synergism Granulocytes/cytology Humans Interferon-gamma/immunology,metabolism,physiology Lymphocyte Activation Lymphotoxin-alpha/immunology,metabolism,physiology Mice Monocytes/cytology Proteins/isolation & purification,physiology Recombinant Proteins/physiology T-Lymphocytes/immunology,metabolism Time Factors
Chemicals
Antibodies, Monoclonal Colony-Stimulating Factors Lymphotoxin-alpha Proteins Recombinant Proteins colony inhibiting factor Interferon-gamma
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Murphy M
Loudon R
Kobayashi M
Trinchieri G
References (59)
59 references, click to expand
  1. Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome.
    Arthritis Rheum. 1983 Aug;26(8):947-53 PMID: 6224491
  2. Differential expression of HLA-DR antigens in subsets of human CFU-GM.
    Blood. 1985 Oct;66(4):788-95 PMID: 3929858
  3. Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia.
    N Engl J Med. 1977 Jan 6;296(1):10-3 PMID: 830263
  4. Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.
    J Immunol. 1980 Oct;125(4):1449-53 PMID: 6967904
  5. Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro.
    J Clin Invest. 1981 Jul;68(1):56-63 PMID: 6972953
  6. Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.
    J Immunol. 1985 Apr;134(4):2185-90 PMID: 2579131
  7. Release of colony-stimulating activity from thymus-derived lymphocytes.
    J Clin Invest. 1975 Mar;55(3):520-7 PMID: 1090636
  8. Heterogeneity of human colony-forming cells.
    Blood. 1978 Feb;51(2):195-206 PMID: 620082
  9. Purification of human lymphotoxin.
    J Immunol. 1972 Oct;109(4):784-90 PMID: 5074332
  10. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    J Immunol. 1984 Jul;133(1):281-5 PMID: 6373929
  11. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.
    Proc Natl Acad Sci U S A. 1985 Jan;82(1):188-92 PMID: 3918301
  12. Identification of the T cell subset that produces human gamma interferon.
    J Immunol. 1982 Jun;128(6):2522-6 PMID: 6176643
  13. Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells.
    Blood. 1982 Feb;59(2):382-92 PMID: 7055645
  14. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.
    J Biol Chem. 1984 Jan 10;259(1):686-91 PMID: 6608523
  15. Human bone marrow colony growth in agar-gel.
    J Cell Physiol. 1970 Aug;76(1):77-84 PMID: 5471041
  16. Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon.
    Cell Immunol. 1985 May;92(2):218-25 PMID: 2986852
  17. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    J Immunol. 1985 Oct;135(4):2502-6 PMID: 3928752
  18. Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.
    J Exp Med. 1985 May 1;161(5):1152-68 PMID: 3838767
  19. T lymphocytes involved in inhibition of granulopoiesis in two neutropenic patients are of the cytotoxic/suppressor (T3+T8+) subset.
    J Clin Invest. 1981 Dec;68(6):1597-600 PMID: 6459342
  20. Monocytes direct T lymphocyte stimulation of human peripheral blood granulocyte-macrophage colony formation.
    Br J Haematol. 1984 Sep;58(1):129-36 PMID: 6331844
  21. The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT.
    Blood. 1980 Oct;56(4):717-27 PMID: 6968234
  22. The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin.
    J Immunol. 1984 Sep;133(3):1083-6 PMID: 6430995
  23. Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures.
    J Immunol. 1974 Feb;112(2):502-10 PMID: 4591973
  24. Studies on the mechanism of allogeneic disease in mice. I. The influence of bone marrow T lymphocytes on the differentiation and proliferation of hemopoietic stem cells.
    Exp Hematol. 1977 Nov;5(6):465-79 PMID: 338329
  25. Pure red blood cell aplasia and chronic lymphocytic leukemia.
    Arch Intern Med. 1974 Oct;134(4):721-4 PMID: 4415396
  26. Characterization of colony-stimulating activity produced by human monocytes and phytohemagglutinin-stimulated lymphocytes.
    Blood. 1977 Nov;50(5):811-21 PMID: 907835
  27. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    J Immunol. 1983 Sep;131(3):1300-5 PMID: 6193183
  28. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
    J Immunol. 1983 May;130(5):2133-41 PMID: 6833758
  29. Natural killer cells suppress human erythroid stem cell proliferation in vitro.
    Blood. 1984 Feb;63(2):260-9 PMID: 6198011
  30. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 PMID: 6392892
  31. Preparation of iodine-131 labelled human growth hormone of high specific activity.
    Nature. 1962 May 5;194:495-6 PMID: 14450081
  32. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    J Exp Med. 1985 Nov 1;162(5):1512-30 PMID: 3932579
  33. Circulating activated suppressor T lymphocytes in aplastic anemia.
    N Engl J Med. 1985 Jan 31;312(5):257-65 PMID: 2981406
  34. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.
    J Exp Med. 1984 Mar 1;159(3):828-43 PMID: 6421983
  35. Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro.
    J Exp Med. 1978 Feb 1;147(2):324-39 PMID: 304881
  36. Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells.
    J Immunol. 1982 Jul;129(1):126-32 PMID: 6177746
  37. "Pure" red cell anemia (erythroblastic hypoplasia) and thymoma.
    Semin Hematol. 1967 Jul;4(3):222-32 PMID: 4864462
  38. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.
    J Immunol. 1981 Mar;126(3):1120-5 PMID: 6161959
  39. Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.
    Proc Natl Acad Sci U S A. 1976 Aug;73(8):2890-4 PMID: 1085449
  40. Coculture studies of 16 untransfused patients with aplastic anemia.
    Blood. 1979 Jul;54(1):180-5 PMID: 444665
  41. Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes.
    J Immunol. 1969 Aug;103(2):170-8 PMID: 5803781
  42. Inhibitory effects of T cells on in vitro granulopoiesis, erythropoiesis, and immunoglobulin production in patients with aplastic anaemia.
    Scand J Haematol. 1982 May;28(5):389-98 PMID: 6214841
  43. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):721-4 PMID: 6334807
  44. Studies of interferon as a regulator of hematopoietic cell proliferation.
    J Immunol. 1985 Oct;135(4):2507-12 PMID: 2411798
  45. Response of resting human peripheral blood natural killer cells to interleukin 2.
    J Exp Med. 1984 Oct 1;160(4):1147-69 PMID: 6434688
  46. Molecular cloning of the complementary DNA for human tumor necrosis factor.
    Science. 1985 Apr 12;228(4696):149-54 PMID: 3856324
  47. Graft-vs.-Host activity of thymocytes: relationship to the role of thymocytes in hemopoiesis.
    Blood. 1972 Jun;39(6):850-61 PMID: 4402170
  48. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
    Science. 1985 Nov 22;230(4728):943-5 PMID: 3933111
  49. Suppressor cell-mediated neutropenia in Felty's syndrome.
    J Clin Invest. 1978 Mar;61(3):738-43 PMID: 305925
  50. Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors.
    Blood. 1979 Sep;54(3):614-27 PMID: 313822
  51. Abnormalities of T-cell subsets in patients with neutropenia and an excess of lymphocytes in the bone marrow.
    Br J Haematol. 1981 May;48(1):137-45 PMID: 7018555
  52. The pathogenesis of the anemia of chronic leukemia; measurement of the life span of the red blood cell with glycine-2-C14.
    J Lab Clin Med. 1954 Dec;44(6):860-74 PMID: 13212252
  53. The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells.
    Blood. 1985 Apr;65(4):858-61 PMID: 2579688
  54. Monoclonal antibodies defining distinctive human T cell surface antigens.
    Science. 1979 Oct 19;206(4416):347-9 PMID: 314668
  55. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
    J Immunol. 1985 Oct;135(4):2492-7 PMID: 3928750
  56. The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro.
    Cell Immunol. 1978 Jul;38(2):388-402 PMID: 307989
  57. Generation of CFUC suppressor T cells in vitro. II. Effect of PHA, PWM, and Con-A on bone marrow and peripheral blood lymphocytes from healthy donors.
    Exp Hematol. 1982 Mar;10(3):256-62 PMID: 6461560
  58. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro.
    J Immunol. 1984 Aug;133(2):769-74 PMID: 6203978
  59. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.
    J Biol Chem. 1985 Feb 25;260(4):2334-44 PMID: 3882692
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1986-07-01
Pages
263-79
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188207
Subset
IM
Grants
NCI NIH HHS · CA10815 · United States
NCI NIH HHS · CA20833 · United States
NCI NIH HHS · CA32898 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]